All Stories

  1. Correction: The neurohypophyseal hormone oxytocin and eating behaviors: a narrative review

    Article • HORMONES, March 2024, Springer Science + Business Media

    Dr Giuseppe Lisco

  2. Chronic Stress as a Risk Factor for Type 2 Diabetes: Endocrine, Metabolic, and Immune Implications

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, March 2024, Bentham Science Publishers

    Dr Giuseppe Lisco, Professor Emilio Jirillo, VINCENZO TRIGGIANI

  3. Is Tirzepatide the New Game Changer in Type 2 Diabetes?

    Article • Endocrines, February 2024, MDPI AG

    Dr Giuseppe Lisco

  4. Semaglutide Modulates Extracellular Matrix Production of LX-2 Cells via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

    Article • International Journal of Molecular Sciences, January 2024, MDPI AG

    Dr Giuseppe Lisco

  5. Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine Department

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, January 2024, Bentham Science Publishers

    Dr Giuseppe Lisco

  6. The pathogenic role of the immune system in erectile dysfunction and Peyronie’s disease: focusing on immunopathophysiology and potential therapeutic strategies

    Article • Sexual Medicine Reviews, January 2024, Oxford University Press (OUP)

    Dr Giuseppe Lisco

  7. Perchlorates in the treatment of hyperthyroidism and thyrotoxicosis: a comprehensive review

    Article • Endocrine, January 2024, Springer Science + Business Media

    Dr Giuseppe Lisco

  8. Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age

    Article • Nutrients, December 2023, MDPI AG

    Dr Giuseppe Lisco

  9. The neurohypophyseal hormone oxytocin and eating behaviors: a narrative review

    Article • HORMONES, November 2023, Springer Science + Business Media

    Dr Giuseppe Lisco

  10. Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes

    Article • Biomedicines, November 2023, MDPI AG

    Dr Giuseppe Lisco

  11. Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study

    Article • Frontiers in Endocrinology, September 2023, Frontiers

    Dr Giuseppe Lisco

  12. Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?

    Article • Endocrine Connections, September 2023, Bioscientifica

    Dr Giuseppe Lisco

  13. Hypothyroidism in older adults: A narrative review

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, August 2023, Bentham Science Publishers

    Dr Giuseppe Lisco

  14. Long‐acting glucagon‐like peptide 1 receptor agonists boost erectile function in men with type 2 diabetes mellitus complaining of erectile dysfunction: A retrospective cohort study

    Article • Andrology, August 2023, Wiley

    Dr Giuseppe Lisco

  15. Computerized nailfold video‐capillaroscopy in type 2 diabetes: A cross‐sectional study on 102 outpatients

    Article • Journal of Diabetes, July 2023, Wiley

    Dr Giuseppe Lisco

  16. When Serum C-Peptide Measurement Drives Adequate Diabetes Mellitus Diagnosis and Therapy: A Case Report

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, June 2023, Bentham Science Publishers

    Dr Giuseppe Lisco, VINCENZO TRIGGIANI

  17. Metformin in elderly Italian with Type 2 Diabetes

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, May 2023, Bentham Science Publishers

    Dr Giuseppe Lisco, franco grimaldi, Olga Eugenia Disoteo

  18. Dyslipidemia and cardiovascular prevention in the elderly: a balance between benefits and risks of statin treatment in a specific population

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, April 2023, Bentham Science Publishers

    Dr Giuseppe Lisco

  19. The role of male hypogonadism, aging, and chronic diseases in characterizing adult and elderly men with erectile dysfunction: a cross-sectional study

    Article • Basic and Clinical Andrology, April 2023, Springer Science + Business Media

    Dr Giuseppe Lisco

  20. Endocrine, Metabolic, and Immune Pathogenesis of Postmenopausal Osteoporosis. Is there a Therapeutic Role in Natural Products?

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, March 2023, Bentham Science Publishers

    Dr Giuseppe Lisco

  21. Right Ventricular Dysfunction and Exercise Impairment in Patients with Heart Failure, Insulin Resistance, and Diabetes Mellitus: Insights from the T.O.S.CA. Registry (Cardiovascular Diabetology 2022)

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, February 2023, Bentham Science Publishers

    Dr Giuseppe Lisco

  22. Iodine Deficiency and Iodine Prophylaxis: An Overview and Update

    Article • Nutrients, February 2023, MDPI AG

    Dr Giuseppe Lisco

  23. Eating Disorders in the Time of the COVID-19 Pandemic: A Perspective

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, February 2023, Bentham Science Publishers

    Dr Giuseppe Lisco, VINCENZO TRIGGIANI

  24. Is Testosterone the “Fountain of Youth” for Aging Men?

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, February 2023, Bentham Science Publishers

    Dr Giuseppe Lisco, Vito Angelo Giagulli, VINCENZO TRIGGIANI, Francesco Mariano

  25. The TNAPP web-based algorithm improves thyroid nodule management in clinical practice: A retrospective validation study

    Article • Frontiers in Endocrinology, January 2023, Frontiers

    Dr Giuseppe Lisco

  26. The Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes Mellitus: A Brief Report

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, January 2023, Bentham Science Publishers

    Dr Giuseppe Lisco

  27. Effect of levothyroxine replacement therapy in patients with subclinical hypothyroidism and chronic heart failure: A systematic review

    Article • Frontiers in Endocrinology, November 2022, Frontiers

    Dr Giuseppe Lisco

  28. Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study

    Article • Nutrients, November 2022, MDPI AG

    Dr Giuseppe Lisco

  29. Neuroendocrine Modulation of Food Intake and Eating Behavior

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, November 2022, Bentham Science Publishers

    Dr Giuseppe Lisco

  30. Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis

    Article • Frontiers in Endocrinology, September 2022, Frontiers

    Dr Giuseppe Lisco

  31. Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study

    Article • Nutrients, June 2022, MDPI AG

    Dr Giuseppe Lisco

  32. Erectile Dysfunction in Patients with Multiple Chronic Conditions: A Cross-Sectional Study

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, May 2022, Bentham Science Publishers

    Dr Giuseppe Lisco

  33. Pancreatic Macrophages and their Diabetogenic Effects: Highlight on Several Metabolic Scenarios and Dietary Approach

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, May 2022, Bentham Science Publishers

    Dr Giuseppe Lisco

  34. Endocrine Disruptors and Obesity: an Overview

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, March 2022, Bentham Science Publishers

    Dr Giuseppe Lisco

  35. Public Health Response to the SARS-CoV-2 Pandemic: Concern about Ultra-Processed Food Consumption

    Article • Foods, March 2022, MDPI AG

    Dr Giuseppe Lisco

  36. Overall sexual function in dysmetabolic obese men with low testosterone levels treated with clomiphene citrate

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, March 2022, Bentham Science Publishers

    Dr Giuseppe Lisco

  37. The pathogenic role of foam cells in atherogenesis: Do they represent novel therapeutic targets?

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, January 2022, Bentham Science Publishers

    Dr Giuseppe Lisco

  38. Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience

    Article • Open Medicine, January 2022, De Gruyter

    Dr Giuseppe Lisco

  39. Commentary to the article “Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry”, Antonio Cittadini et al. Eur J Prev Cardiol. 2021

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, December 2021, Bentham Science Publishers

    Dr Giuseppe Lisco

  40. Eating Disorders and Type 1 Diabetes: a perspective

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, November 2021, Bentham Science Publishers

    Dr Giuseppe Lisco

  41. Signal Transduction of Mineralocorticoid and Angiotensin II Receptors in the Central Control of Sodium Appetite: A Narrative Review

    Article • International Journal of Molecular Sciences, October 2021, MDPI AG

    Dr Giuseppe Lisco

  42. Endocrine system dysfunction and chronic heart failure: a clinical perspective

    Article • Endocrine, October 2021, Springer Science + Business Media

    Dr Giuseppe Lisco

  43. Trends in Coffee and Tea Consumption during the COVID-19 Pandemic

    Article • Foods, October 2021, MDPI AG

    Dr Giuseppe Lisco

  44. Angiotensin II-Vasopressin Interactions in The Regulation of Cardiovascular Functions. Evidence for an Impaired Hormonal Sympathetic Reflex in Hypertension and Congestive Heart Failure

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, October 2021, Bentham Science Publishers

    Dr Giuseppe Lisco, Vito Angelo Giagulli, VINCENZO TRIGGIANI

  45. TSH Variations in Chronic Heart Failure Outpatients: Clinical Correlates and Outcomes

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, October 2021, Bentham Science Publishers

    Dr Giuseppe Lisco, Natale Daniele Brunetti, VINCENZO TRIGGIANI

  46. Hyperglycemia-induced Immune System Disorders in Diabetes Mellitus and the Concept of Hyperglycemic Memory of Innate Immune Cells: A perspective

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, September 2021, Bentham Science Publishers

    Dr Giuseppe Lisco

  47. Covid-19 in Man: A Very Dangerous Affair

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, September 2021, Bentham Science Publishers

    Dr Giuseppe Lisco, Vito Angelo Giagulli, VINCENZO TRIGGIANI

  48. Assessment of Burnout Levels before and during COVID-19 Pandemic: A Web-Based Survey by the (Italian) Association of Medical Endocrinologists (AME).

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, July 2021, Bentham Science Publishers

    Dr Giuseppe Lisco

  49. Prevalence of Erectile Dysfunction According to Chronic Comorbid Health Conditions: a Cross-sectional Study.

    Article • July 2021, Research Square

    Dr Giuseppe Lisco

  50. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme

    Article • Journal of Clinical Medicine, June 2021, MDPI AG

    Dr Giuseppe Lisco

  51. Endocrine-Disrupting Chemicals: Introduction to the Theme

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, April 2021, Bentham Science Publishers

    Dr Giuseppe Lisco

  52. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects

    Article • Journal of Endocrinological Investigation, March 2021, Springer Science + Business Media

    Dr Giuseppe Lisco

  53. Oxytocin Signaling Pathway: From Cell Biology to Clinical Implications

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, January 2021, Bentham Science Publishers

    Dr Giuseppe Lisco, Dr Vito Angelo Giagulli, VINCENZO TRIGGIANI

  54. Bone Disruption and Environmental Pollutants

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, January 2021, Bentham Science Publishers

    Dr Giuseppe Lisco

  55. Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition

    Article • Geriatrics, October 2020, MDPI AG

    Dr Giuseppe Lisco

  56. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review

    Article • Endocrine, August 2020, Springer Science + Business Media

    Dr Giuseppe Lisco

  57. Critical evaluation of different available guidelines for late‐onset hypogonadism

    Article • Andrology, July 2020, Wiley

    Dr Giuseppe Lisco

  58. Fixed-Ratio Combinations of Basal Insulin and Glp-1ra in the Management of Type 2 Diabetes Mellitus: Highlight from Literature

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, July 2020, Bentham Science Publishers

    Dr Giuseppe Lisco, VINCENZO TRIGGIANI

  59. Worse progression of COVID‐19 in men: Is Testosterone a key factor?

    Article • Andrology, June 2020, Wiley

    Dr Giuseppe Lisco

  60. Interference on Iodine Uptake and Human Thyroid Function by Perchlorate-Contaminated Water and Food

    Article • Nutrients, June 2020, MDPI AG

    Dr Giuseppe Lisco

  61. Congestive Heart Failure and Thyroid Dysfunction: The Role of the Low T3 Syndrome and Therapeutic Aspects

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, June 2020, Bentham Science Publishers

    Dr Giuseppe Lisco, VINCENZO TRIGGIANI

  62. Paraganglioma-like medullary thyroid cancer diagnosed during pregnancy.

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, February 2020, Bentham Science Publishers

    VINCENZO TRIGGIANI, Dr Giuseppe Lisco

  63. Computerized Video-Capillaroscopy Alteration Related to Diabetes Mellitus and Its Complications

    Article • January 2018, Springer Science + Business Media

    Dr Giuseppe Lisco